Dopamine transporter genotype as a risk factor for obesity in African-American smokers

Obesity Research

Volumn 10, Issue 12, 2002, Pages 1232-1240

  Epstein, Leonard H ^a   Jaroni, Jodie L ^a   Paluch, Rocco A ^a   Leddy, John J ^a   Vahue, Holly E ^a   Hawk, Larry ^b   Wileyto, E Paul ^c   Shields, Peter G ^d   Lerman, Caryn ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

African American; Dopamine transport; Smoking

Indexed keywords

PIERINAE;

EID: 0040074774     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2002.168     Document Type: Article

References (69)

1. Comuzzie AG, Allison DB. The search for human obesity genes. Science. 1998;280:1374-7.
2. Faith MS, Pietrobelli A, Nunez C, Heo M, Heymsfield SB, Allison DB. Evidence for independent genetic influences on fat mass and body mass index in a pediatric twin sample. Pediatrics. 1999;104:61-7.
3. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 1996;20:1-25.
4. Martel P, Fantino M. Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study. Pharmacol Biochem Behav. 1996;53:221-6.
5. Epstein LH, Saelens BE. Behavioral economics of obesity: food intake and energy expenditure. In: Bickel WK, Vuchinich RE, eds. Reframing Health Behavior Change with Behavioral Economics. Mahwah, NJ: Lawrence Erlbaum; 2000, pp. 293-311.
6. Saelens BE, Epstein LH. The reinforcing value of food in obese and non-obese women. Appetite. 1996;27:41-50.
7. Ingram DK. Age-related decline in physical activity: generalization to nonhumans. Med Sci Sports Exerc. 2000; 32:1623-9.
8. Jaber M, Jones S, Giros B, Caron MG. The dopamine transporter: a crucial component regulating dopamine transmission. Mov Disord. 1997;12:629-33.
9. Gaytan O, Ghelani D, Martin S, Swann A, Dafny N. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. Brain Res. 1997;777:1-12.
10. Schreiber HL, Wood GW, Carlson RH. The role of locomotion in conditioning methylphenidate-induced locomotor activity. Pharmacol Biochem Behav. 1976;4:393-5.
11. Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand. 1999; 100:3-16.
12. Foltin RW, Fischman MW, Nautiyal C. The effects of cocaine on food intake of baboons before, during, and after a period of repeated desipramine. Pharmacol Biochem Behav. 1990;36:869-74.
13. Bina KG, Cincotta AH. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology. 2000;71:68-78.
14. Salamone JD. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav Brain Res. 1994;61:117-33.
15. Bannon MJ, Granneman JG, Kapatos G. The dopamine transporter: potential involvement in neuropsychiatrie disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995, pp. 179-188.
16. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenics. 2001;1:152-6.
17. Heinz A, Goldman D, Jones DW, et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology. 2000;22:133-9.
18. Jacobsen LK, Staley JK, Zoghbi SS, et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am Psychiatry. 2000;157:1700-3.
19. Martinez D, Gelernter J, Abi-Dargham A, et al. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology. 2001;24:553-60.
20. Cincotta AH, Tozzo E, Scislowski PW. Bromocriptine/ SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice. Life Sci. 1997;61: 951-6.
21. Scislowski PW, Tozzo E, Zhang Y, Phaneuf S, Prevelige R, Cincotta AH. Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists. Int J Obes Relat Metab Disord. 1999;23:425-31.
22. Figlewicz DP, Patterson TA, Johnson LB, Zavosh A, Israel PA, Szot P. Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats. Brain Res Bull. 1998;46: 199-202.
23. Klesges RC, Meyers AW, Klesges LM, LaVasque MD. Smoking, body weight, and their effects on smoking behavior: a comprehensive review of the literature. Psychol Bull. 1989; 106:204-30.
24. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. JAMA. 1994;272:205-11.
25. Grundy SM. Primary prevention of coronary heart disease: integrating risk assessment with intervention. Circulation. 1999;100:988-98.
26. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128-30.
27. Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc. 1999;31:S663-S7.
28. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677-85.
29. Subar AF, Harlan LC, Mattson ME. Food and nutrient intake differences between smokers and non-smokers in the US. Am Public Health. 1990;80:1323-9.
30. Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry. 2000;15:79-89.
31. Noble EP. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenics. 2000;1:309-33.
32. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988;85:5274-8.
33. Allison DB, Heshka S, Neale MC, Heymsfield SB. Race effects in the genetics of adolescents' body mass index. Int J Obes Relat Metab Disord. 1994;18:363-8.
34. Harlan WR, Landis JR, Flegal KM, Davis CS, Miller ME. Secular trends in body mass index in the United States, 1960-1980. Am J Epidemiol. 1988;128:1065-74.
35. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998:22: 39-47.
36. Kumanyika S. Obesity in black women. Epidemiol Rev. 1987;9:31-50.
37. Striegel-Moore RH, Wilfley DE, Caldwell MB, Needham ML, Brownell KD. Weight-related attitudes and behaviors of women who diet to lose weight: a comparison of black dieters and white dieters. Obes Res. 1996;4:109-16.
38. Kumanyika S, Wilson JF, Guilford-Davenport M. Weight-related attitudes and behaviors of black women. J Am Diet Assoc. 1993;93:416-22.
39. Kumanyika S. Racial and ethnic issues in diet and cancer epidemiology. Adv Exp Med Biol. 1994;354:59-70.
40. Lerman C, Caporaso NE, Main D, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 1999;18:14-20.
41. Vandenbergh DJ, Persico AM, Hawkins AL, et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics. 1992;14:1104-6.
42. Rowland ML. Self-reported weight and height. Am J Clin Nutr. 1990;52:1125-33.
43. NHLBI Obesity Education Initiative Expert Panel. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res. 1998;6(suppl 2):51S-209S.
44. Lerman C, Gold K, Audrain J, et al. Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol. 1997;16:87-99.
45. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet. 2001;357:354-7.
46. Wilkinson L. SYSTAT 6.0 for Windows. Chicago, IL: SPSS, Inc.; 1996.
47. Lindquist CH, Gower BA, Goran MI. Role of dietary factors in ethnic differences in early risk of cardiovascular disease and type 2 diabetes. Am J Clin Nutr. 2000;71:725-32.
48. Yanovski JA, Yanovski SZ, Filmer KM, et al. Differences in body composition of black and white girls. Am J Clin Nutr. 1996;64:833-9.
49. Gower BA, Nagy TR, Trowbridge CA, Dezenberg C, Goran MI. Fat distribution and insulin response in prepubertal African American and white children. Am J Clin Nutr. 1998;67:821-7.
50. Bild DE, Jacobs DR Jr, Sidney S, Haskell WL, Anderssen N, Oberman A. Physical activity in young black and white women. The CARDIA Study. Ann Epidemiol. 1993;3:636-44.
51. Washburn RA, Kline G, Lackland DT, Wheeler FC. Leisure time physical activity: are there black/white differences? Prev Med. 1992;21:127-35.
52. Folsom AR, Cook TC, Sprafka JM, Burke GL, Norsted SW, Jacobs DR Jr. Differences in leisure-time physical activity levels between blacks and whites in population-based samples: the Minnesota Heart Survey. J Behav Med. 1991;14:1-9.
53. Pivarnik JM, Bray MS, Hergenroeder AC, Hill RB, Wong WW. Ethnicity affects aerobic fitness in U.S. adolescent girls. Med Sci Sports Exerc. 1995;27:1635-8.
54. Jakicic JM, Wing RR. Differences in resting energy expenditure in African-American vs Caucasian overweight females. Int J Obes Relat Metab Disord. 1998;22:236-42.
55. Foster GD, Wadden TA, Vogt RA. Resting energy expenditure in obese African American and Caucasian women. Obes Res. 1997;5:1-8.
56. Chitwood LF, Brown SP, Lundy MJ, Dupper MA. Metabolic propensity toward obesity in black vs white females: responses during rest, exercise and recovery. Int J Obes Relat Metab Disord. 1996;20:455-62.
57. Patterson BH, Harlan LC, Block G, Kahle L. Food choices of whites, blacks, and Hispanics: data from the 1987 National Health Interview Survey. Nutr Cancer. 1995;23:105-19.
58. Popkin BM, Siega-Riz AM, Haines PS. A comparison of dietary trends among racial and socioeconomic groups in the United States. N Engl J Med. 1996;335:716-20.
59. Cook TH, Nies MA, Hepworth JT. Race differences in the relationships between dietary nutrients and overweight in women. Health Care Women Int. 2000;21:41-51.
60. Garenc C, Perusse L, Chagnon YC, et al. The hormone-sensitive lipase gene and body composition: the HERITAGE Family Study. Int J Obes Relat Metab Disord. 2002;26:220-7.
61. Stanley BG, Magdalin W, Seirafi A, Thomas WJ, Leibowitz SF. The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s). Brain Res. 1993;604:304-17.
62. Meier AH, Cincotta AH. Circadian rhythms regulate the expression of the thrifty genotype/phenotype. 1996;4:464-87.
63. Gordon-Larsen P, McMurray RG, Popkin BM. Determinants of adolescent physical activity and inactivity patterns. Pediatrics. 2000;105:E83.
64. Sullivan PF, Eaves LJ, Kendler KS, Neale MC. Genetic case-control association studies in neuropsychiatry. Arch Gen Psychiatry. 2001;58:1015-24.
65. Perusse L, Chagnon YC, Weisnagel SJ, et al. The human obesity gene map: the 2000 update. Obes Res. 2001;9:135-69.
66. Patterson TA, Brot MD, Zavosh A, Schenk JO, Szot P, Figlewicz DP. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology. 1998; 68:11-20.
67. Sclafani A, Rendel A. Food deprivation-induced activity in dietary obese, dietary lean, and normal-weight rats. Behav Biol. 1978;24:220-8.
68. Weed JL, Lane MA, Roth GS, Speer DL, Ingram DK. Activity measures in rhesus monkeys on long-term calorie restriction. Physiol Behav. 1997;62:97-103.
69. Faith MS, Johnson SL, Allison DB. Putting the behavior into the behavior genetics of obesity. Behav Genet. 1997;27:423-39.